iBionext raises EUR 46M in growth fund's first close

iBionext raised EUR 46 million ($51.4 million) in the first close of its iBionext Growth Fund. Launched earlier this year, the fund has a EUR 100 million ($111.8 million) target.

iBionext launches and develops biotech, medtech and connected medical device companies, all located at a single site in Paris. The firm has created seven companies since 2012, including gene therapy company GenSight Biologics S.A. (Euronext:SIGHT) and tissue repair start-up Gecko Biomedical S.A.S. (Paris, France). ...